Peptide derivatives of exendin-4


Ontology type: sgo:Patent     


Patent Info

DATE

N/A

AUTHORS

Martin Gotthardt , Martin Béhé , Thomas Behr , Burkhard J. Göke

ABSTRACT

In the current invention peptides, which are derived from GLP-1 (glucagon-like peptide-1) and exendin-3 and/or exendin-4, are provided which bond to the GLP-receptor and can be used, labeled or unlabeled, for the production of an agent for diagnostic and therapy of benign and malignant diseases, in which GLP-1 receptor expression plays a role. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3039", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Martin Gotthardt", 
        "type": "Person"
      }, 
      {
        "name": "Martin B\u00e9h\u00e9", 
        "type": "Person"
      }, 
      {
        "name": "Thomas Behr", 
        "type": "Person"
      }, 
      {
        "name": "Burkhard J. G\u00f6ke", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0001-2998(95)80014-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002027562"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250050903", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013633156", 
          "https://doi.org/10.1007/s001250050903"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250050903", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013633156", 
          "https://doi.org/10.1007/s001250050903"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1006/abio.1997.9998", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026365238"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.272.34.21201", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026832290"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bi0014498", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055162497"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm9909645", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055959772"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-125-1-199607010-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073700529"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "description": "

In the current invention peptides, which are derived from GLP-1 (glucagon-like peptide-1) and exendin-3 and/or exendin-4, are provided which bond to the GLP-receptor and can be used, labeled or unlabeled, for the production of an agent for diagnostic and therapy of benign and malignant diseases, in which GLP-1 receptor expression plays a role.

", "id": "sg:patent.US-8268781-B2", "keywords": [ "derivative", "exendin-4", "invention", "Glucagon-Like Peptide 1", "bond", "receptor", "agent", "therapy", "malignant disease", "receptor expression" ], "name": "Peptide derivatives of exendin-4", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.10253.35", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-8268781-B2" ], "sdDataset": "patents", "sdDatePublished": "2019-03-07T15:34", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com.uberresearch.data.dev.patents-pipeline/full_run_10/sn-export/5eb3e5a348d7f117b22cc85fb0b02730/0000100128-0000348334/json_export_962f20a5.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-8268781-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-8268781-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-8268781-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-8268781-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

65 TRIPLES      14 PREDICATES      30 URIs      17 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-8268781-B2 schema:about anzsrc-for:3039
2 schema:author Nb66fce40ef6b4069a4ff2f2e7a0f47b8
3 schema:citation sg:pub.10.1007/s001250050903
4 https://doi.org/10.1006/abio.1997.9998
5 https://doi.org/10.1016/s0001-2998(95)80014-x
6 https://doi.org/10.1021/bi0014498
7 https://doi.org/10.1021/jm9909645
8 https://doi.org/10.1074/jbc.272.34.21201
9 https://doi.org/10.7326/0003-4819-125-1-199607010-00005
10 schema:description <p num="p-0001">In the current invention peptides, which are derived from GLP-1 (glucagon-like peptide-1) and exendin-3 and/or exendin-4, are provided which bond to the GLP-receptor and can be used, labeled or unlabeled, for the production of an agent for diagnostic and therapy of benign and malignant diseases, in which GLP-1 receptor expression plays a role.</p>
11 schema:keywords Glucagon-Like Peptide 1
12 agent
13 bond
14 derivative
15 exendin-4
16 invention
17 malignant disease
18 receptor
19 receptor expression
20 therapy
21 schema:name Peptide derivatives of exendin-4
22 schema:recipient https://www.grid.ac/institutes/grid.10253.35
23 schema:sameAs https://app.dimensions.ai/details/patent/US-8268781-B2
24 schema:sdDatePublished 2019-03-07T15:34
25 schema:sdLicense https://scigraph.springernature.com/explorer/license/
26 schema:sdPublisher Nd0fad2e5076444468e2feea035e7c833
27 sgo:license sg:explorer/license/
28 sgo:sdDataset patents
29 rdf:type sgo:Patent
30 N0d61ac8432a144c8b46c104928f204b4 rdf:first N2d8b0bc1480642d3b1bb9cf497050cb6
31 rdf:rest rdf:nil
32 N2d8b0bc1480642d3b1bb9cf497050cb6 schema:name Burkhard J. Göke
33 rdf:type schema:Person
34 N3b8675b4377d497d805f14412095b448 schema:name Thomas Behr
35 rdf:type schema:Person
36 N659f11c89fe7483dbd24912a87dc0744 rdf:first Nda3e2b9a7e344b75bfd7e694301f8327
37 rdf:rest N7e24369dc05849c3986f47fcf83e24ee
38 N7e24369dc05849c3986f47fcf83e24ee rdf:first N3b8675b4377d497d805f14412095b448
39 rdf:rest N0d61ac8432a144c8b46c104928f204b4
40 Nb66fce40ef6b4069a4ff2f2e7a0f47b8 rdf:first Nc807f169c94c4583b8eea1c900e4c25c
41 rdf:rest N659f11c89fe7483dbd24912a87dc0744
42 Nc807f169c94c4583b8eea1c900e4c25c schema:name Martin Gotthardt
43 rdf:type schema:Person
44 Nd0fad2e5076444468e2feea035e7c833 schema:name Springer Nature - SN SciGraph project
45 rdf:type schema:Organization
46 Nda3e2b9a7e344b75bfd7e694301f8327 schema:name Martin Béhé
47 rdf:type schema:Person
48 anzsrc-for:3039 schema:inDefinedTermSet anzsrc-for:
49 rdf:type schema:DefinedTerm
50 sg:pub.10.1007/s001250050903 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013633156
51 https://doi.org/10.1007/s001250050903
52 rdf:type schema:CreativeWork
53 https://doi.org/10.1006/abio.1997.9998 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026365238
54 rdf:type schema:CreativeWork
55 https://doi.org/10.1016/s0001-2998(95)80014-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1002027562
56 rdf:type schema:CreativeWork
57 https://doi.org/10.1021/bi0014498 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055162497
58 rdf:type schema:CreativeWork
59 https://doi.org/10.1021/jm9909645 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055959772
60 rdf:type schema:CreativeWork
61 https://doi.org/10.1074/jbc.272.34.21201 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026832290
62 rdf:type schema:CreativeWork
63 https://doi.org/10.7326/0003-4819-125-1-199607010-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073700529
64 rdf:type schema:CreativeWork
65 https://www.grid.ac/institutes/grid.10253.35 schema:Organization
 




Preview window. Press ESC to close (or click here)


...